UnitedHealth Group is facing a staggering loss in its market value following the former CEO’s sudden murder. The shocking assassination of Brian Thompson last December took the world by storm as all eyes focused on Luigi Mangione — the man who was allegedly responsible for gunning him down.

The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements that critics have been seeking.

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the healthcare system “needs to function better.”

UnitedHealth Group CEO Andrew Witty told analysts that the company is positioned well for growth in 2025. This comes just a month after the CEO of its insurance unit was murdered.

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In 2024, the US economy was stronger than expected;

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 billion, continues to navigate a complex landscape of opportunities and challenges as it maintains its position as a dominant force in the healthcare industry.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies for high costsIn his first public remarks since the murder of

UnitedHealth Group shares fell Thursday after the company reported fourth-quarter results that missed analysts' expectations.

FCPI's portfolio shows resilience in consumer staples and healthcare, but faces uncertainty in energy and basic materials sectors. Read more about FCPI ETF here.